Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratumoral Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00849459
What this trial is testing

Gene Therapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Max Sung 3
Early research (Phase 1)Study completedNCT00844623
What this trial is testing

TK-based Suicide Gene Therapy for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Clinica Universidad de Navarra, Universidad de Navarra 10
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Very early researchUnknownNCT06478459
What this trial is testing

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT01976585
What this trial is testing

In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy

Who this might be right for
Low-Grade B-cell Lymphoma
Joshua Brody 21
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Early research (Phase 1)Study completedNCT01924689
What this trial is testing

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 24
Early research (Phase 1)Looking for participantsNCT07625423
What this trial is testing

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Who this might be right for
Head & Neck CancerNasopharyngeal Cancinoma (NPC)
West China Hospital 9
Testing effectiveness (Phase 2)UnknownNCT04362722
What this trial is testing

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Who this might be right for
Carcinoma, Basal CellCarcinoma, Cutaneous Squamous Cell
Philogen S.p.A. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07491783
What this trial is testing

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

Who this might be right for
HNSCCSoft Tissue Cancer
Sichuan Enray Pharmaceutical Sciences Company 52
Testing effectiveness (Phase 2)Ended earlyNCT03323398
What this trial is testing

Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies

Who this might be right for
Relapsed/Refractory Solid Tumor Malignancies or LymphomaOvarian Cancer
ModernaTX, Inc. 79
Early research (Phase 1)Study completedNCT02035657
What this trial is testing

A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 10
Very early researchStudy completedNCT06413095
What this trial is testing

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma
Presage Biosciences 13
Very early researchLooking for participantsNCT06700070
What this trial is testing

Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma AdultTriple Negative Breast Cancer
Pure Biologics S.A. 12
Early research (Phase 1)Looking for participantsNCT07648472
What this trial is testing

The Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.

Who this might be right for
Advanced Solid Tumors
Joint Biosciences Ltd. 18
Early research (Phase 1)UnknownNCT00262327
What this trial is testing

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Sun Yat-sen University 20
Early research (Phase 1)Study completedNCT00668512
What this trial is testing

Intratumoral Injection Of Alpha-Gal Glycosphingolipids

Who this might be right for
Metastatic Melanoma
University of Massachusetts, Worcester 12
Early research (Phase 1)Ended earlyNCT03249792
What this trial is testing

Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)

Who this might be right for
Solid TumorLymphoma
Merck Sharp & Dohme LLC 140
Early research (Phase 1)Study completedNCT05727839
What this trial is testing

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Who this might be right for
Cutaneous TumorMalignant Solid Tumor
Immorna Biotherapeutics, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT04685499
What this trial is testing

Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease

Who this might be right for
Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
Weill Medical College of Cornell University 1
Next Page